Kyntra Bio (KYNB) Gross Profit (2020 - 2025)
Historic Gross Profit for Kyntra Bio (KYNB) over the last 6 years, with Q3 2025 value amounting to $1.0 million.
- Kyntra Bio's Gross Profit rose 202083.33% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.6 million, marking a year-over-year increase of 8840.99%. This contributed to the annual value of -$8.4 million for FY2024, which is 11951.64% down from last year.
- Kyntra Bio's Gross Profit amounted to $1.0 million in Q3 2025, which was up 202083.33% from $1.3 million recorded in Q2 2025.
- Over the past 5 years, Kyntra Bio's Gross Profit peaked at $152.7 million during Q3 2021, and registered a low of -$64.3 million during Q4 2023.
- In the last 5 years, Kyntra Bio's Gross Profit had a median value of $1.5 million in 2025 and averaged $10.9 million.
- Its Gross Profit has fluctuated over the past 5 years, first crashed by 95527.64% in 2024, then surged by 202083.33% in 2025.
- Quarter analysis of 5 years shows Kyntra Bio's Gross Profit stood at $13.4 million in 2021, then surged by 119.42% to $29.4 million in 2022, then crashed by 318.5% to -$64.3 million in 2023, then surged by 79.11% to -$13.4 million in 2024, then surged by 107.57% to $1.0 million in 2025.
- Its last three reported values are $1.0 million in Q3 2025, $1.3 million for Q2 2025, and $1.5 million during Q1 2025.